Asthma remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) following treatment with benralizumab or mepolizumab

被引：0
|
作者：
Bourdin, Arnaud [1 ]
Wechsler, Michael E. [2 ]
Jackson, David J. [3 ]
Siddiqui, Salman [4 ]
Baudy, Peter [5 ]
Menzies-Gow, Andrew [6 ]
Necander, Sofia [7 ]
Shavit, Anat [6 ]
Walton, Claire [8 ]
机构：
[1] Univ Montpellier, Dept Resp Dis, CHU Montpellier, INSERM, Montpellier, France
[2] Natl Jewish Hlth, Dept Med, Denver, CO USA
[3] Kings Coll London, Guys Severe Asthma Ctr, London, England
[4] Imperial Coll London, Hammersmith & Royal Brompton Hosp, Natl Heart & Lung Inst, London, England
[5] AstraZeneca, Resp & Immunol US Med, Wilmington, DE USA
[6] AstraZeneca, BioPharmaceutials Med, Cambridge, England
[7] AstraZeneca, Late Stage Resp & Immunol, BioPharmaceut R&D, AstraZeneca Med, Gothenburg, Sweden
[8] AstraZeneca, Late Stage Resp & Immunol, BioPharmaceut R&D, Cambridge, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA5364
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Benralizumab in Eosinophilic Granulomatosis with Polyangiitis
    Cottu, Adrien
    Groh, Matthieu
    Desaintjean, Charlene
    Marchand-Adam, Sylvain
    Guillevin, Loic
    Puechal, Xavier
    Lazaro, Estibaliz
    Samson, Maxime
    Taille, Camille
    Durel, Cecile-Audrey
    Diot, Elisabeth
    Nicolas, Sarah
    Guilleminault, Laurent
    Ebbo, Mikael
    Cathebras, Pascal
    Dupin, Clairelyne
    Yildiz, Halil
    Belfeki, Nabil
    Pugnet, Gregory
    Chauvin, Pierre
    Jouneau, Stephane
    Lifermann, Francois
    Martellosio, Jean-Philippe
    Cottin, Vincent
    Terrier, Benjamin
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1351 - 1354
  • [32] MEPOLIZUMAB FOR THE TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS.
    Smith, Rona
    RHEUMATOLOGY, 2017, 56 : 15 - 15
  • [33] Benralizumab in eosinophilic granulomatosis with polyangiitis
    Laorden, Daniel
    Romero, David
    Dominguez-Ortega, Javier
    MEDICINA CLINICA, 2022, 158 (09): : 441 - 442
  • [34] Effect of immunosuppressant coadministration with mepolizumab for moderate to severe eosinophilic granulomatosis with polyangiitis(EGPA)
    Tsurikisawa, Naomi
    Masumoto, Nami
    Motobayashi, Yuto
    Terada, Kosuke
    Kodama, Yuka
    Yamashita, Yuga
    Masumitsu, Hinako
    Kaneko, Takeshi
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [35] Benralizumab for eosinophilic granulomatosis with polyangiitis
    Cottu, Adrien
    Groh, Matthieu
    Desaintjean, Charlene
    Marchand-Adam, Sylvain
    Guillevin, Loic
    Puechal, Xavier
    Beaumesnil, Stacy
    Lazaro, Estibaliz
    Samson, Maxime
    Taille, Camille
    Durel, Cecile-Audrey
    Diot, Elizabeth
    Nicolas, Sarah
    Guilleminault, Laurent
    Ebbo, Mikael
    Cathebras, Pascal
    Dupin, Clairelyne
    Yildiz, Halil
    Belfeki, Nabil
    Pugnet, Gregory
    Chauvin, Pierre
    Jouneau, Stephane
    Lifermann, Francois
    Martellosio, Jean-Philippe
    Cottin, Vincent
    Terrier, Benjamin
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (12) : 1580 - 1586
  • [36] Mepolizumab Treatment of Pediatric Eosinophilic Granulomatosis With Polyangiitis
    Joseph, Mathew X.
    Jenkins, Lauren E.
    Wechsler, Michael E.
    Davis, Loretta S.
    JAMA DERMATOLOGY, 2018, 154 (04) : 486 - +
  • [37] Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
    Portacci, Andrea
    Campisi, Raffaele
    Buonamico, Enrico
    Nolasco, Santi
    Pelaia, Corrado
    Crimi, Nunzio
    Benfante, Alida
    Triggiani, Massimo
    Spadaro, Giuseppe
    Caiaffa, Maria Filomena
    Scioscia, Giulia
    Detoraki, Aikaterini
    Valenti, Giuseppe
    Papia, Francesco
    Tomasello, Alessandra
    Scichilone, Nicola
    Pelaia, Girolamo
    Crimi, Claudia
    Carpagnano, Giovanna Elisiana
    ERJ OPEN RESEARCH, 2023, 9 (05)
  • [38] Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?"
    Caminati, Marco
    Crisafulli, Ernesto
    Lunardi, Claudio
    Micheletto, Claudio
    Festi, Giuliana
    Maule, Matteo
    Giollo, Alessandro
    Orsolini, Giovanni
    Senna, Gianenrico
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07): : 2943 - 2944
  • [39] Mepolizumab for eosinophilic granulomatosis with polyangiitis
    Loïc Guillevin
    Nature Reviews Rheumatology, 2017, 13 : 518 - 519
  • [40] Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis Reply
    Wechsler, Michael E.
    Pouliquen, Isabelle
    Steinfeld, Jonathan
    Bradford, Eric S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (02) : 622 - 622
12345